Infinity Pharmaceuticals, Inc.'s stock has a beta of 2.68 so it is more volatile than the market overall which by definition has a beta of 1. The share price has already crossed its 20 days moving average, floating at a distance of 18.5% and sits 24.07% higher versus its 50 days moving average.
In the market the company is trading up by 68.86% at $2.82 and has one of the biggest price gains of the day.
The consensus recommendation - averaging the work of 15 analysts - of 2.3 for AMC Entertainment Holdings, Inc. (NASDAQ:INFI) on Wednesday, March 9 with "Market Outperform" rating. On Monday, August 10 the stock rating was upgraded by Zacks to "Hold".
Infinity Pharmaceuti (NASDAQ:INFI)'s distance from 20 day simple moving average is 0.3186 along with distance from 50 day simple moving average of 1.2 whereas its distance from 200 day simple moving average is 1.64.
With a total market value of $0, Infinity Pharmaceuticals has with a one year low of $0.84 and a one year high of $3.84. The stock is trading for about -61.72% less than its 52-week high. Infinity Pharmaceuticals has a 12 month low of $0.84 and a 12 month high of $3.84. Infinity Pharmaceuticals, Inc. earnings have risen with an annualized rate of 16.6% over the last 5 years.
While taking a glance at financials, we can look at a number of key indicators. Return on assets is -59.20% and Return on equity (ROE) is -88.10% while it's Return on Investment (ROI) of -30.30%. The Relative Strength Index (RSI) is a recognized technical indicator used to assess the strength and weakness of momentum in price action. A lower P/B ratio could mean that the stock is undervalued.
The company's price to free cash flow for trailing twelve months is 0. For the most recent quarter, quick ratio was 6.30, current ratio was 6.30, LT Debt/Equity ratio was 0.35 and Total Debt/Equity ratio stands at 0.36, while Payout ratio is 0. Also, Infinity Pharmaceuticals, Inc.
The focus shift on performance of the Mylan N.V. (NASDAQ:MYL) that has shown a discernible change in trend levels over the path of recent market activity. Oclaro Inc (NASDAQ:OCLR) has a market capitalization of $1.46 Billion and most recently 170.73 Million outstanding shares have been calculated.
The company had seen its current volume reaching at 1.17 million shares in the last trade. They now have a United States dollars 13 price target on the stock.
According to the recommendations from 11 analysts stock has mean rating of 1 on the shares of Oclaro Inc (NASDAQ:OCLR). On Tuesday, June 14 the stock rating was downgraded by to "Neutral". 1 have given the stock a Hold rating, 0 as Underperform and 0 as Sell. The 50 day moving average moved up $1.62 and the 200 day average went up $1.18 or +72.01%. (NASDAQ:INFI). Rock Springs Cap Mgmt L P invested in 270,000 shares or 0.02% of the stock. A P/B ratio of less than 1.0 can indicate that a stock is undervalued, while a ratio of greater than 1.0 may indicate that a stock is overvalued.